JPRN-UMIN000052065招募中Unknown
Patients with major depressive disorder,Clinical study of sleep EEG measurement using DCT (Decentralized Clinical Trial) - Patients with major depressive disorder,Clinical study of sleep EEG measurement using DCT (Decentralized Clinical Trial)
Medical Corporation Chiseikai Tokyo Center Clinic0 个研究点目标入组 60 人开始时间: 2023年9月1日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients with major depressive disorder: 1)Persons with schizophrenia and other comorbid psychotic disorders according to DSM-5 diagnostic criteria. Also, those receiving treatment for diseases of the respiratory system, circulatory system, digestive system, immune system, liver, kidney, haematopoietic function or endocrine function. 2)Persons with any of the following comorbidities based on DSM-5 diagnostic criteria: delirium, dementia, substance-related disorder, borderline personality disorder, eating disorder, obsessive-compulsive disorder, panic disorder, post-traumatic stress disorder, intellectual capacity disorder, autistic spectrum disorder. 3)Persons at significant risk of suicide who have had suicidal thoughts within the past 3months or suicidal behaviour within 1year prior to the start of the screening period, corresponding to items 4 or 5 of the Columbia Suicide Rating Scale (C-SSRS). 4)Patients who are hospitalised or scheduled to be hospitalised for treatment during the study period. 5)Persons who take benzodiazepines,lithium carbonate or antihistamine drugs during the study period from 2days before POINT2 to the end of POINT2 and from 2days before POINT3 to the end of POINT4. 6)Persons with alcohol abuse or illicit drug abuse or a history of such abuse. 7)Persons who are judged by the researcher or others to be unsuitable for the study. Healthy adults: 1)Persons receiving treatment for diseases of the respiratory, circulatory, mental, nervous, digestive, immune, liver, kidney, haematopoietic or endocrine systems. 2)Persons for whom the Brief Structured Interview for Mental Illness (M.I.N.I.) screen version questionnaire suggests suspicion of a mental disorder or who have a history of such a disorder. 3)Persons who answered 'yes' to question 1 or 2 on suicidal ideation in the Columbia Suicide Rating Scale (C-SSRS), or who answered 'yes' to any of the questions on suicidal behaviour. 4)Same as 6) 7) above.
研究者
相似试验
招募中
Unknown
Clinical study to examine the usefulness of the brain network marker program using fMRI for the diagnosis of major depressive disorderJPRN-jRCTs062220063Okada Go390
招募中
Unknown
Major depression in Borderline Personality disorder: A distinct clinical presentation?CTRI/2023/06/053617Department of Psychiatry
尚未招募
不适用
A randomized controlled trial of a modified neurolinguistic programming technique to improve emotional control in patients with depression in primary care.depression in primary care with a Patient Health Questionnaire score of between 10 and 20 (mild to moderate major depression)Mental Health - DepressiondepressionACTRN12612000859886Prof Bruce Arroll200
已完成
不适用
The investigation of treatment for major depression compared monotherapy of mirtazapine, sertraline or duloxetine with combination therapy of mirtazapine and sertraline, or mirtazapine and duloxetineMajor depressionJPRN-UMIN000004567Kenichi Osada500
尚未招募
不适用
The treatment of depressive disorders with online psychological treatment supported by a cliniciaDepressive disorders, depression, depressive symptoms, major depressive disorder, depressieve stoornissen, depressieve klachtenNL-OMON28356niversity Medical Center Groningen302